CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-29 | Canepa John J Chief Financial Officer | Purchase | +10,125 | $8.00 | $81K | 10,125 |
| 2021-07-29 | Caffo Nathan Chief Business Officer | Purchase | +6,000 | $8.00 | $48K | 6,000 |
| 2021-07-29 | Manning Paul B Director | Purchase | +20,000 | $7.30 | $146K | 56,000 |
| 2021-07-27 | Manning Paul B Director | Purchase | +36,000 | $7.36 | $265K | 36,000 |
Page 2 of 2 · 24 trades